Principal Pathologist
Regeneron Pharmaceuticals
Summary
The Pathology group within Regeneron's Drug Safety and Pharmacometrics organization is looking for a Principal Pathologist who is excited to help advance innovative medicines from discovery through development. In this highly collaborative role, you will provide critical pathology expertise across the drug development continuum, including pathology peer review of Regeneron toxicology studies and close partnership with research scientists to support the discovery, characterization, and preclinical development of diverse therapeutic modalities, including large-molecule therapeutics, gene therapies, and oligonucleotide-based drugs targeting a broad range of diseases.
Job description
When & Where
This position will be based on-site in our Tarrytown, NY offices four days per week.
Discover Your Role
- Apply your expertise in toxicologic pathology to help shape research programs that support the discovery and development of transformative medicines.
- Serve as the study pathologist for in-house discovery studies and produce high-quality pathology reports that inform scientific decision-making and support regulatory submissions.
- Provide digital or glass-slide pathology peer review for Regeneron toxicology studies conducted at contract research organizations.
- Leverage digital image analysis, when appropriate, to strengthen study interpretation and scientific insight.
- Contribute to the continued development of a forward-looking, in-house digital pathology program.
- Present your scientific contributions through internal and external forums that support regulatory and discovery programs.
- Contribute to scientific publications, including manuscripts, abstracts, posters, and oral presentations.
- Stay connected with the toxicologic pathology community through seminars, workshops, and conferences.
This Role Requires
- DVM or PhD in Pathology
- Board certification in veterinary anatomic pathology (DACVP or DECVP).
- Experience at a contract research organization is preferred.
Requirements
- DVM or PhD in Pathology
- Board certification in veterinary anatomic pathology (DACVP or DECVP)
- Experience at a contract research organization is preferred
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Insurance benefits
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.